# ICU (SeaStar Medical Holding Corp) - SEC EDGAR Financial Statements

> SeaStar Medical Holding Corp reported $2.17M in revenue and a net loss of $14.68M for the trailing twelve months ended September 30, 2026 (up 247.0% year over year), with a 92.6% gross margin and a -692.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/ICU
- Markdown: https://convexityos.com/fundamentals/ICU.md
- SEC CIK: 0001831868
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001831868&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $2.17M | +247.0% YoY |
| Operating Income | TTM | -$14.99M | -692.4% margin |
| Net Income | TTM | -$14.68M | -678.2% net margin |
| Diluted EPS | TTM | -- | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $3.99M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.23M | $135K | $0 | -- | -- |
| Cost of Revenue | $53K | $0 | $0 | -- | -- |
| **Gross Profit** | $1.18M | $135K | $0 | -- | -- |
| Research & Development | $7.52M | $9.11M | $5.97M | $2.50M | $2.77M |
| Total Operating Expenses | $13.36M | $17.98M | $14.21M | $11.61M | $4.45M |
| **Operating Income** | -$12.18M | -$17.84M | -$14.21M | -$11.61M | -$4.45M |
| Interest Income | $325K | $101K | $0 | -- | $12K |
| Interest Expense | $31K | $244K | $1.08M | $630K | $212K |
| Income Before Tax | -$12.15M | -$24.83M | -$26.23M | -$12.19M | -$4.60M |
| Income Tax Expense | $3.0K | $3.0K | $0 | $1.0K | -$1.0K |
| **Net Income** | -$12.15M | -$24.83M | -$26.23M | -$12.19M | -$4.60M |
| Basic EPS | -$5.86 | -$66.33 | -$302.60 | -$370.00 | -$157.50 |
| **Diluted EPS** | -- | -$66.30 | -$302.60 | -$370.00 | -$157.50 |
| Basic Shares Outstanding | 2.1M | 374.4K | 86.7K | 32.8K | 29.0K |
| Diluted Shares Outstanding | -- | 374.4K | 86.7K | 32.8K | 29.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $635K | $615K | $495K | $420K | $183K | $338K | $293K | $67K |
| Cost of Revenue | $48K | $54K | $46K | $12K | $14K | $27K | $0 | $0 |
| **Gross Profit** | $587K | $561K | $449K | $408K | $169K | $311K | $293K | $67K |
| Research & Development | $3.57M | $2.52M | $2.34M | $2.20M | $1.85M | $1.04M | $2.43M | $2.74M |
| Total Operating Expenses | $5.17M | $4.35M | $4.05M | $3.42M | $3.75M | $2.07M | $4.12M | $4.83M |
| **Operating Income** | -$4.58M | -$3.79M | -$3.60M | -$3.02M | -$3.58M | -$1.76M | -$3.82M | -$4.77M |
| Interest Income | $54K | $69K | $91K | $125K | $107K | $45K | $48K | $19K |
| Interest Expense | $2.0K | $8.0K | $6.0K | $13K | $0 | $9.0K | $11K | -$253K |
| Income Before Tax | -$4.53M | -$3.73M | -$3.52M | -$2.90M | -$3.47M | -$2.00M | -$3.77M | -$4.42M |
| Income Tax Expense | $0 | $0 | $3.0K | $0 | $0 | $0 | $3.0K | $0 |
| **Net Income** | -$4.53M | -$3.73M | -$3.52M | -$2.90M | -$3.47M | -$2.00M | -$3.77M | -$4.42M |
| Basic EPS | -$1.03 | -$0.91 | -$0.90 | -- | -$1.30 | -$1.77 | -$4.38 | -- |
| **Diluted EPS** | -- | -- | -- | -- | -- | -$1.80 | -$4.40 | -- |
| Basic Shares Outstanding | 4.4M | 4.1M | 3.9M | -- | 2.7M | 1.1M | 861.8K | -- |
| Diluted Shares Outstanding | -- | -- | -- | -- | -- | 1.1M | 861.8K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2023 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $11.98M | $1.82M | $176K | $73K | $13K | $725K | $47K | $52K | $38K |
| **Cash & Short-Term Investments** | $11.98M | $1.82M | $176K | $73K | $13K | $725K | $47K | $0 | $0 |
| Accounts Receivable, Net | $237K | $112K | $0 | -- | -- | -- | -- | -- | -- |
| Inventory | $66K | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $13.58M | $3.77M | $2.31M | $1.23M | $1.23M | $2.21M | $1.52M | $601K | $269K |
| Other Non-Current Assets | $578K | $892K | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $578K | $892K | $1.21M | $1.28M | $1.36M | $1.44M | $1.52M | $2.0K | $0 |
| **Total Assets** | $14.16M | $4.66M | $3.51M | $2.51M | $2.60M | $3.65M | $3.04M | $603K | $269K |
| Accounts Payable | $948K | $3.05M | $4.37M | $5.04M | $4.36M | $3.02M | $1.93M | $85K | -- |
| Short-Term Debt | -- | $574K | $565K | -- | $5.91M | $493K | $1.18M | -- | -- |
| Deferred Revenue (Current) | -- | $0 | $100K | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $3.74M | $6.84M | $13.05M | $12.80M | $14.35M | $21.28M | $16.15M | $3.12M | $249K |
| Long-Term Debt | -- | -- | $3.58M | $5.72M | -- | $5.25M | $6.47M | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | $0 | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $0 | $0 | $4.34M | $5.72M | $0 | $5.75M | $7.65M | $299K | $0 |
| **Total Liabilities** | $3.74M | $6.84M | $17.38M | $18.52M | $14.35M | $27.02M | $23.80M | $3.42M | $249K |
| **Total Debt (incl. Leases)** | -- | $574K | $4.14M | $5.72M | $5.91M | $5.75M | $7.65M | -- | -- |
| Common Stock | $4.0K | $2.0K | $1.0K | $3.0K | $2.0K | $1.0K | $1.0K | -- | -- |
| Retained Earnings | -$151.7M | -$139.6M | -$114.7M | -$105.3M | -$98.05M | -$95.60M | -$88.50M | -$76.31M | -$5.2K |
| **Total Stockholders' Equity** | $10.42M | -$2.18M | -$13.87M | -$16.02M | -$11.76M | -$23.38M | -$20.76M | -$2.82M | $1.77M |
| Total Equity | $10.42M | -$2.18M | -$13.87M | -$16.02M | -$11.76M | -$23.38M | -$20.76M | -$2.82M | $1.77M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.99M | $6.96M | $9.35M | $11.98M | $13.76M | $6.30M | $5.30M | $1.82M |
| **Cash & Short-Term Investments** | $3.99M | $6.96M | $9.35M | $11.98M | $13.76M | $6.30M | $5.30M | $1.82M |
| Accounts Receivable, Net | $178K | $208K | $179K | $237K | $221K | $217K | $110K | $112K |
| Inventory | $45K | $77K | $57K | $66K | $83K | $77K | $44K | $0 |
| **Total Current Assets** | $4.97M | $8.23M | $10.76M | $13.58M | $14.87M | $7.65M | $6.78M | $3.77M |
| Other Non-Current Assets | $343K | $421K | $499K | $578K | $656K | -- | -- | $892K |
| **Total Non-Current Assets** | $343K | $421K | $499K | $578K | $656K | $736K | $7.42M | $892K |
| **Total Assets** | $5.31M | $8.65M | $11.26M | $14.16M | $15.53M | $8.38M | $14.20M | $4.66M |
| Accounts Payable | $1.47M | $750K | $719K | $948K | $2.02M | $3.16M | $3.40M | $3.05M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | $574K |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Current Liabilities** | $4.84M | $4.35M | $3.95M | $3.74M | $4.07M | $5.04M | $7.03M | $6.84M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $4.84M | $4.35M | $3.95M | $3.74M | $4.07M | $5.04M | $7.03M | $6.84M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | -- | -- | $574K |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$163.5M | -$159.0M | -$155.2M | -$151.7M | -$148.8M | -$145.3M | -$143.3M | -$139.6M |
| **Total Stockholders' Equity** | $469K | $4.30M | $7.32M | $10.42M | $11.46M | $3.34M | $565K | -$2.18M |
| Total Equity | $469K | $4.30M | $7.32M | $10.42M | $11.46M | $3.34M | $565K | -$2.18M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$12.15M | -$24.83M | -$26.23M | -$12.19M | -$4.60M |
| Stock-Based Compensation | $624K | $887K | $1.93M | $1.31M | $14K |
| Change in Receivables | -$125K | -$112K | $0 | -- | -- |
| Change in Inventory | -$66K | $0 | -- | $0 | $55K |
| Change in Payables | -$2.10M | -$1.28M | $2.44M | $1.55M | -$297K |
| **Operating Cash Flow** | -$13.60M | -$16.01M | -$10.29M | -$7.79M | -$5.11M |
| **Investing Cash Flow** | -- | -- | -- | -- | -$105.6M |
| Common Stock Issued | $16.13M | $17.44M | $4.74M | $0 | -- |
| **Financing Cash Flow** | $23.76M | $17.65M | $10.41M | $7.33M | $2.82M |
| **Net Change in Cash** | $10.16M | $1.64M | $129K | -$463K | -$2.30M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$4.53M | -$3.73M | -$3.52M | -$2.90M | -$3.47M | -$2.00M | -$3.77M | -$4.42M |
| Stock-Based Compensation | $163K | -$99K | $91K | $70K | $290K | $97K | $167K | $212K |
| Change in Receivables | $30K | -$29K | $58K | -$16K | -$4.0K | -$107K | $2.0K | -$44K |
| Change in Inventory | $32K | -$20K | $9.0K | $17K | -$6.0K | -$33K | -$44K | $0 |
| Change in Payables | $717K | $31K | -$229K | -$1.07M | -$1.14M | -$239K | $351K | -$423K |
| **Operating Cash Flow** | -$3.37M | -$2.99M | -$2.76M | -$4.09M | -$3.84M | -$3.01M | -$2.65M | -$4.69M |
| Common Stock Issued | $539K | $810K | $329K | $1.79M | $9.18M | $3.59M | $1.57M | $3.86M |
| **Financing Cash Flow** | $403K | $605K | $129K | $2.31M | $11.30M | $4.01M | $6.13M | $4.43M |
| **Net Change in Cash** | -$2.97M | -$2.39M | -$2.63M | -$1.78M | $7.46M | $1.01M | $3.48M | -$263K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 95.7% | 100.0% | -- | -- | -- |
| **Operating Margin** | -986.6% | -13216.3% | -- | -- | -- |
| **Net Profit Margin** | -984.6% | -18392.6% | -- | -- | -- |
| Return on Equity (ROE) | -116.6% | -- | -- | -- | -- |
| Return on Assets (ROA) | -85.8% | -533.1% | -746.7% | -401.3% | -762.2% |
| Current Ratio | 3.63x | 0.55x | 0.18x | 0.09x | 0.19x |
| Quick Ratio | 3.61x | 0.55x | 0.01x | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | +814.1% | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +774.8% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 92.6% | 92.6% | 93.1% | 95.7% | 95.3% | 96.5% | 100.0% | 100.0% |
| **Operating Margin** | -692.4% | -816.6% | -832.5% | -986.5% | -1580.5% | -1932.2% | -4138.8% | -13216.3% |
| **Net Profit Margin** | -678.2% | -795.5% | -828.6% | -984.6% | -1551.1% | -1915.3% | -3716.1% | -18392.6% |
| Return on Equity (ROE) | -3130.9% | -317.2% | -162.7% | -116.6% | -119.2% | -439.1% | -2815.0% | -- |
| Return on Assets (ROA) | -276.5% | -157.6% | -105.6% | -85.8% | -88.0% | -175.0% | -112.0% | -533.1% |
| Current Ratio | 1.03x | 1.89x | 2.73x | 3.63x | 3.66x | 1.52x | 0.96x | 0.55x |
| Quick Ratio | 1.02x | 1.87x | 2.71x | 3.61x | 3.64x | 1.50x | 0.96x | 0.55x |
| **Revenue Growth (YoY)** | +247.0% | +82.0% | +68.9% | +526.9% | +169.1% | -- | -- | -- |
| Gross Profit Growth (YoY) | +247.3% | +80.4% | +53.2% | +509.0% | +148.5% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
